![]() ![]() Mohamad Makhzoumi, co-president of NEA, agreed with that, saying in a written statement that among value-based care providers, “Strive stood out with its proven performance advancing clinical outcomes and simultaneously reducing total cost of care.” Strive Health is the only company doing both, he added. Some competitors are just pursuing health insurance companies as their main customer, while others go after kidney specialists. Riopelle said that Strive Health heard from the investors that it had the right approach to the market. Joining them in the round were existing investors CapitalG (Alphabet), Echo Ventures, Town Hall Ventures, Ascension Ventures and Redpoint. Strive Health itself has now secured $166 million in Series C funding in a round led by NEA and five new investors, including strategic investor CVS Health Ventures. It also partners with over 600 nephrology providers in 10 states. Overall, Strive Health now manages over $2.5 billion of annual medical spending and has grown to 550 employees serving 80,000 patients across 30 states. Louis and since then its value-based care approach has led to an over 20% reduction in the total cost of kidney care and a 42% reduction in hospitalizations. The company launched in April 2020 with 700 patients in St. That’s important because of the 37 million Americans that have kidney disease, only 10% are diagnosed and over $400 billion a year is spent on kidney care, he explained. This way, Strive Health can provide what Riopelle called a “super targeted intervention.” Simply put, the company takes in patient data and puts it through machine learning programs to identify what stage of kidney disease a patient might be and then be able to predict the probability of the disease’s progression. Strive Health brings value via technology-enabled care interventions and seamless integration with local providers to form an integrated care delivery system that follows a patient from chronic kidney disease to end-stage kidney disease. OMERS Growth Equity leads Carrum Health’s $45M Series B to expand cancer care Over time, that will create more value in the system than just seeing a patient many, many, many times.” “My definition of ‘value-based care’ is making sure the organizations that are responsible for caring for patients are really focused on the outcomes and the quality that they drive. “While that is necessary, important and valuable, it doesn’t take into account fee-for-value, which is if you do a lot of good work, you should create a bunch of value and have very high-quality outcomes,” Riopelle said. Chris Riopelle, co-founder and CEO of Strive Health told TechCrunch that healthcare used to be mainly fee-for-service where the incentive was if you did more work, more reimbursement would come. When it comes to your kidneys, Strive Health is working to provide value-based care specifically to the 37 million adults living with chronic kidney disease. ![]() Just this week I just wrote about Carrum Health’s $45 million Series B investment to offer value-based cancer care. That kind of care, called “value-based,” has been referenced a lot in recent years. It’s widely known that healthcare is expensive in the United States and that patients are looking for better quality of care that is more cost-effective. ![]()
0 Comments
Leave a Reply. |